Co-Diagnostics Analyst Ratings
Co-Diagnostics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/14/2022 | 64.38% | HC Wainwright & Co. | $9 → $6 | Maintains | Buy |
| 08/15/2022 | 146.58% | HC Wainwright & Co. | $12 → $9 | Maintains | Buy |
| 08/12/2022 | 36.99% | Sidoti & Co. | → $5 | Downgrades | Buy → Neutral |
| 05/16/2022 | 228.77% | HC Wainwright & Co. | $15 → $12 | Maintains | Buy |
| 11/12/2021 | 310.96% | HC Wainwright & Co. | $16 → $15 | Maintains | Buy |
| 03/29/2021 | — | Maxim Group | Downgrades | Buy → Hold | |
| 03/26/2021 | 338.36% | HC Wainwright & Co. | $30 → $16 | Maintains | Buy |
| 12/15/2020 | 721.92% | HC Wainwright & Co. | $29 → $30 | Maintains | Buy |
| 11/17/2020 | 694.52% | HC Wainwright & Co. | $33 → $29 | Maintains | Buy |
| 08/14/2020 | 804.11% | HC Wainwright & Co. | $35 → $33 | Maintains | Buy |
| 05/20/2020 | 721.92% | Maxim Group | → $30 | Upgrades | Hold → Buy |
| 05/18/2020 | 858.9% | HC Wainwright & Co. | $20 → $35 | Reiterates | → Buy |
| 03/03/2020 | — | Maxim Group | Downgrades | Buy → Hold | |
| 02/24/2020 | 9.59% | HC Wainwright & Co. | $2 → $4 | Maintains | Buy |
| 04/09/2019 | -45.21% | Maxim Group | → $2 | Initiates Coverage On | → Buy |
| 03/11/2019 | -45.21% | HC Wainwright & Co. | → $2 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变化 | 上一页/当前额定值 |
|---|---|---|---|---|---|
| 11/14/2022 | 64.38% | HC Wainwright & Co. | 9 美元 → 6 美元 | 维护 | 买 |
| 08/15/2022 | 146.58% | HC Wainwright & Co. | 12 美元 → 9 美元 | 维护 | 买 |
| 2022 年 12 月 8 日 | 36.99% | Sidoti & Co. | → 5 美元 | 降级 | 买入 → 中性 |
| 05/16/2022 | 228.77% | HC Wainwright & Co. | 15 美元 → 12 美元 | 维护 | 买 |
| 11/12/2021 | 310.96% | HC Wainwright & Co. | 16 美元 → 15 美元 | 维护 | 买 |
| 03/29/2021 | — | Maxim 集团 | 降级 | 买入 → 持有 | |
| 03/26/2021 | 338.36% | HC Wainwright & Co. | 30 美元 → 16 美元 | 维护 | 买 |
| 2020 年 12 月 15 日 | 721.92% | HC Wainwright & Co. | 29 美元 → 30 美元 | 维护 | 买 |
| 11/17/2020 | 694.52% | HC Wainwright & Co. | 33 美元 → 29 美元 | 维护 | 买 |
| 08/14/2020 | 804.11% | HC Wainwright & Co. | 35 美元 → 33 美元 | 维护 | 买 |
| 05/20/2020 | 721.92% | Maxim 集团 | → 30 美元 | 升级 | 持有 → 买入 |
| 05/18/2020 | 858.9% | HC Wainwright & Co. | 20 美元 → 35 美元 | 重申 | → 购买 |
| 03/03/2020 | — | Maxim 集团 | 降级 | 买入 → 持有 | |
| 2020 年 2 月 24 日 | 9.59% | HC Wainwright & Co. | 2 美元 → 4 美元 | 维护 | 买 |
| 04/09/2019 | -45.21% | Maxim 集团 | → 2 美元 | 开启覆盖范围 | → 购买 |
| 03/11/2019 | -45.21% | HC Wainwright & Co. | → 2 美元 | 开启覆盖范围 | → 购买 |
What is the target price for Co-Diagnostics (CODX)?
联合诊断（CODX）的目标价格是多少？
The latest price target for Co-Diagnostics (NASDAQ: CODX) was reported by HC Wainwright & Co. on November 14, 2022. The analyst firm set a price target for $6.00 expecting CODX to rise to within 12 months (a possible 64.38% upside). 4 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2022年11月14日公布了Co-Diagnostics（纳斯达克股票代码：CODX）的最新目标股价。这家分析公司将目标价设定为6.00美元，预计CODX将在12个月内升至64.38％（可能上涨64.38％）。去年，有4家分析公司公布了评级。
What is the most recent analyst rating for Co-Diagnostics (CODX)?
Co-Diagnostics（CODX）的最新分析师评级是多少？
The latest analyst rating for Co-Diagnostics (NASDAQ: CODX) was provided by HC Wainwright & Co., and Co-Diagnostics maintained their buy rating.
Co-Diagnostics（纳斯达克股票代码：CODX）的最新分析师评级由HC Wainwright & Co. 提供，Co-Diagnostics维持了买入评级。
When is the next analyst rating going to be posted or updated for Co-Diagnostics (CODX)?
Co-Diagnostics（CODX）的下一个分析师评级将在何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Co-Diagnostics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Co-Diagnostics was filed on November 14, 2022 so you should expect the next rating to be made available sometime around November 14, 2023.
分析师在进行了广泛的研究后得出了股票评级，包括浏览公开财务报表，与Co-Diagnostics的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月这样做一次，因此每家公司每年应该获得4次评级。Co-Diagnostics的最新评级是在2022年11月14日提交的，因此您应该预计下一个评级将在2023年11月14日左右公布。
Is the Analyst Rating Co-Diagnostics (CODX) correct?
分析师评级联合诊断 (CODX) 是否正确？
While ratings are subjective and will change, the latest Co-Diagnostics (CODX) rating was a maintained with a price target of $9.00 to $6.00. The current price Co-Diagnostics (CODX) is trading at is $3.65, which is out of the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但最新的Co-Diagnostics（CODX）评级保持不变，目标价为9.00美元至6.00美元。Co-Diagnostics（CODX）目前的交易价格为3.65美元，超出了分析师的预测区间。